Elizabeth Gallegos

Founded in 1999, Credit Suisse Asset Management LLC (CSAM) is a registered investment advisor headquartered in New York City. The firm is an indirect wholly-owned subsidiary of Credit Suisse Group AG (NYSE: CS), a publicly owned foreign bank holding company based in Switzerland.

Crosslink Capital, Inc. (Crosslink) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Menlo Park, California. The firm was founded in 1999 as Omega Venture Partners, Inc. Crosslink provides investment advisory services to investment funds.

Pickwick Capital Partners LLC is a broker/dealer located in White Plains, New York. They provide an array of trading and execution services for their clients. The firm does not provide any internal research

Immunophotonics, Inc. develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine. Its vaccine process under development, inCVAX, is a two injection procedure into one or more selected tumors: The first injection is a needle with an optical fiber (coupled to a laser) that heats selected tumor(s) locally; The second injection is experimental drug product, a proprietary synthesized carbohydrate polymer, that is intended to recruit and activate antigen-presenting cells, potentially triggering a cascade that leads to a systemic anti-tumor immune response. The company was founded by Lu Alleruzzo and Tomas Hode in 2009 and is headquartered in St. Louis, MI.

Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Prostate Management Diagnostics, Inc. engages in the provision of research and test of fluid-based screening tool to identify patients at risk of prostate cancer. It performs research on a series of genetic markers that could determine whether a prostrate cancer is indolent or aggressive in patients newly diagnosed with the disease. The company was founded by Christopher B. Ehrlich and Douglas C. Fisher in 2014 and is headquartered in Sausalito, CA.

Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia.

GTL Resources Ltd. engages in production and sale of ethanol. It operates as a bio-refining company. The firm produces liquids, such as methanol and ethanol from stranded gas, corn and other feedstocks. The company operates through its subsidiary, Illinois River Energy LLC. It was founded in 1993 and is headquartered in London, the United Kingdom.

White Energy Holding Co. LLC operates as a holding company with interest in producing ethanol. The company is headquartered in Frisco, TX.

BioGenerator (Venture Capital) (BioGenerator) is a venture capital subsidiary of BioGenerator founded in 2003. The firm is headquartered in St. Louis, Missouri.

GreenLight Biosciences, Inc. engages in a biotechnology company.. It delivers attractive solution for production of chemicals and fuels from renewable resources, eliminating the need for petroleum feedstocks. The company was founded by Andrey J. Zarur, Marta Ortega-Valle, and James R. Swartz and is headquartered in Medford, MA.

Credit Value Partners LP (CVP) is a SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded within Credit Suisse in June 2010 and began operating as an independent firm in October 2010. In 2016, the firm was acquired by CVP Holdings LLC, ultimately owned by Pollard Family Investments LLC. CVP provides discretionary investment management services to unregistered pooled investment vehicles, private funds, and separately managed accounts.

Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

CoverCress, Inc. operates as a renewable fuel company. It develops and commercializes field pennycress as an oilseed crop that is used to produces oil for industrial and renewable fuels, and meal for nutritious livestock feed. The company was founded by Vijay Chauhan, Dennis M. Plummer and Mike Roth and is headquartered in St. Louis, MO.

Edison Agrosciences, Inc. provides agricultural biotechnology services. The firm specializes in agriculture, biotechnology and rubber. The company was founded by Matthew B. Crisp and Thomas M. Hohn and is headquartered in Creve Coeur, MO.

Thirstie, Inc. provides on-demand alcohol delivery services. It operates platform for wine, beer and spirits that engages customers through an editorial platform. The company was founded by Maxim Razmakhin and Devaraj Southworth in 2013 and is headquartered in New York, NY.

Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO.

Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015.

Fulcrum Global Capital LLC (Fulcrum Global Capital) is an venture capital firm founded in 2016 by Keith Harrington and John Peryam. The firm is headquartered in Shawnee, Kansas.

Resilient Biotics, Inc. designs microbiome-based therapeutics and screening methods. The firm offers prevention and precision treatment for deadly infectious diseases. The company was founded by Christopher P. Belnap and is headquartered in El Cerrito, CA.

Solis Agrosciences, Inc. is a plant sciences company located in the 39N Innovation District. The American company offers technology and research services to agricultural innovators with the goal of designing and delivering new biotech plant traits in multiple crops using their proprietary Plant Pipeline as a Service (PPaaS™) for gene-edited and transgenic plant generation and characterization. Solis has a team of experienced scientists, entrepreneurs, and agtech leaders to support research needs and accelerate agricultural innovation to solve food and climate challenges. The company was founded by Charlie W. Bolten and the CEO is Tom Cohen.

Lewis & Clark AgriFood (Lewis & Clark AgriFood) is a venture capital firm founded in 2016. The firm headquartered in Saint Louis, Missouri.

MediBeacon, Inc. provides optical diagnostic products and services. It offers Optical Renal Function Monitor, a platform focused on kidney function monitoring in real-time at the point-of-care. The company was founded by Steven J. Hanley and Richard B. Dorshow in 2012 and is headquartered in St. Louis, MO.

Hypha Life Sciences LLC operates as a research services company providing biotechnology innovators access to premium R&D capabilities in genetic engineering and metabolomics. The company is based in Wilmington, DE. The company was founded by Charles Bolten and Tom Cohen. The CEO is Tom Cohen.